Lindbrook Capital’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Lindbrook Capital’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,051	Closed	-$21K	–	3079
2022 Q3	$21K	Buy	1,051 +905	+620%	+$11.9K	﹤0.01%	970
2022 Q2	$1K	Buy	146 +6	+4%	+$42	﹤0.01%	2449
2022 Q1	$1K	Buy	+140	New	+$1.49K	﹤0.01%	2444

Lindbrook Capital's FMTX Position: Q4 2022 in Review

Lindbrook Capital sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 1,051 shares — an estimated $21K sold.

Lindbrook Capital first reported a position in FMTX in Q1 2022 and held it in 3 quarters. The position peaked at $21K in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Lindbrook Capital reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Lindbrook Capital sold 1,051 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $21K.
Lindbrook Capital first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
Lindbrook Capital's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $21K in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Lindbrook Capital's 13F filing for Q4 2022, filed 25 Jan 2023.